1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PPP1R13B CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF714 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA CCSAP CTRPv2 pan-cancer AAC 0.11 0.002
mRNA KDF1 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA STMN4 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA WEE2 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA ZNF596 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA AP3M2 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA KIAA1549L CTRPv2 pan-cancer AAC -0.12 0.002
mRNA CLEC11A CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV